trial

Treatment of Mania Symptoms With Drug Therapy

NCTId NCT00183443
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 75 (actual)
Sponsored by Palo Alto Veterans Institute for Research
Primary completion 2010-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
75 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2005-02
Primary completion
2010-11
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Divalproex-extended release (DVP-ER)LithiumQuetiapine

Sponsors

Palo Alto Veterans Institute for ResearchLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Trisha Suppes, MD, PhDPrincipal Investigator

Sites

1 total
Palo Alto, United States

Linked catalysts

1
Treatment of Mania Symptoms With Drug Therapy — primary completion2010-11

Facts & assertions

4 sourced
Enrollment
75
Phase
PHASE3
Primary Completion Date
2010-11
Status
COMPLETED
relationships
The graph out of here
drug
Divalproex-extended release (DVP-ER)
drug
Lithium
drug
Quetiapine
drug
lead_sponsor
Palo Alto Veterans Institute for Research
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Mania
indication
Bipolar Disorder
indication
Psychotic Disorders
indication
investigator
Trisha Suppes, MD, PhD
person